“…Fifteen studies 10,17,19,24,34,37,47,56–58,60,61,63,69,81 included children and adolescents with mixed pain conditions, 13 studies 2,9,15,20,29,31,32,42,52,59,66,68,80 with juvenile idiopathic arthritis, 10 studies 3–5,14,28,35,40,46,62,71 with headache/migraine, and 7 studies 36,41,44,55,67,72,79 with adolescent idiopathic scoliosis. Nineteen were cross-sectional studies, 3–5,9,19,28,32,35,41,42,44,46,47,59,62,69,71,72,80 25 were cohort studies 2,10,14,15,17,20,24,29,31,36,37,40,52,55–58,60,61,63,66–68,79,81 of which 11 provided some type of intervention with cost data collected at baseline or before the intervention, 10,17,20,24,37,52,56–58,61,63 and 1 was a randomized controlled trial with cost data collected at baseline. 34 Seventeen studies were conducted in the United States (37.8%), 3,10,14,17,19,24,34,35,41,55,61,62,66,69,71,79,81 7 in Germany (15.6%), 37,42,46,47,56–58 5 in Canada (11%), 2,9,15,44,63 3 in Turkey (6.7%), 28,72,80 2 in Brazil (4.4%), 4,5 2 in the United Kingdom (4.4%), 60,68 2 in the Netherlands (4.4%) 31,52 1 in Finland (2.2%), 20 1 in Italy (2.2%), 40 1 in Singapore (2.2%), 67 1 in China (2.2%), 36 and 1 in India (2.2%).…”